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Abstract	17	 Pathogenic	 anaerobes	 Brachyspira	 spp.	 are	 responsible	 for	 an	 increasing	 number	 of	18	 Intestinal	Spirochaetosis	(IS)	cases	in	livestock	against	which	few	approved	treatments	19	 are	available.	Tiamulin	is	used	to	treat	swine	dysentery	caused	by	Brachyspira	spp.	and	20	 recently	has	been	used	to	handle	avian	intestinal	spirochaetosis	(AIS).	The	therapeutic	21	 dose	used	in	chickens	requires	further	evaluation	since	cases	of	bacterial	resistance	to	22	 tiamulin	 have	 been	 reported.	 In	 this	 study,	 we	 evaluated	 the	 impact	 of	 tiamulin	 at	23	 varying	 concentrations	 on	 the	 metabolism	 of	 B.	 pilosicoli	 using	 a	 1H-NMR-based	24	
metabonomics	 approach	 allowing	 the	 capture	 of	 the	 overall	 bacterial	 metabolic	25	 response	 to	 antibiotic	 treatment.	 Based	 on	 growth	 curve	 studies,	 tiamulin	 impacted	26	 bacterial	growth	even	at	very	 low	concentration	(0.008	µg/ml)	although	 its	metabolic	27	 activity	was	barely	affected	72	h	post	exposure	to	antibiotic	treatment.	Only	the	highest	28	 dose	of	 tiamulin	 tested	(0.250	µg/ml)	caused	a	major	metabolic	shift.	Results	showed	29	 that	 below	 this	 concentration,	 bacteria	 could	maintain	 a	 normal	metabolic	 trajectory	30	 despite	significant	growth	inhibition	by	the	antibiotic,	which	may	contribute	to	disease	31	 reemergence	post	antibiotic	treatment.	Indeed,	we	confirmed	that	B.	pilosicoli	remained	32	 viable	even	after	exposition	to	the	highest	antibiotic	dose.	This	paper	stresses	the	need	33	 to	 ensure	 new	 evaluation	 of	 bacterial	 viability	 post	 bacteriostatic	 exposure	 such	 as	34	 tiamulin	 to	 guarantee	 treatment	 efficacy	 and	 decrease	 antibiotic	 resistance	35	 development.		36	 	37	
Highlight	38	
• B.	pilosicoli	metabolism	was	characterized	using	1H	NMR-based	metabonomics	39	
• Tiamulin	 inhibited	 B.	pilosicoli	 growth	 at	 very	 low	 dose	 (respectively	 <	 0.016	40	 µg/mL	and	>	0.032	µg/mL)	41	
• B.	pilosicoli	 metabolism	 is	 not	 inhibited	 for	 tiamulin	 concentration	 superior	 to	42	 0.032	µg/mL	43	
• B.	 pilosicoli	metabolism	 is	 completely	 repressed	 at	 0.250	 µg/mL,	 but	 remain	44	 viable	45	
1.	Introduction	46	
Brachyspira	 pilosicoli	 is	 a	 gram-negative	 bacterium	 of	 the	 Spirochaetes	 family.	 It	47	 colonizes	the	lower	part	of	the	gastrointestinal	track	of	a	large	range	of	hosts	including	48	
pigs,	birds,	humans,	monkeys,	dogs	and	horses	[1-4].	Once	in	the	intestinal	 lumen,	the	49	 bacterium	is	attracted	via	chemotaxis	to	the	mucin	barrier	[5,6]	through	which	it	swims	50	 mediated	 by	 its	 unique	 “corkscrew”	 shape	 and	 rotation	 of	 its	 periplasmic	 flagella	 [7]	51	 aided	by	 the	secretion	of	mucine	degrading	enzymes	 [5,8].	B.	pilosicoli	 attaches	 to	 the	52	 enterocytes	in	an	end	on	fashion	and	may	also	infect	these	cells	[9-12].	Colonization	by	53	
B.	pilosicoli	 can	 lead	 to	 the	 development	 of	 intestinal	 spirochaetosis	 (IS),	 the	 signs	 of	54	 which	 are	 diarrhea,	 poor	 overall	 condition,	 dehydration	 and	 decreased	 growth	 rate.	55	 Mortality	is	often	significant	when	the	disease	is	left	untreated	[13-15],	a	consequence	56	 that	makes	IS	a	serious	economic	and	welfare	problem	in	farming.		57	 Tiamulin	is	effective	 in	 treating	 IS	 caused	by	Brachyspira	hyodystenteriae,	B.	hampsonii	58	
and	B.	pilosicoli	 in	 swine	 [16-18]	 and	 in	 poultry	 [19-21].	 Tiamulin	 is	 a	 bacteriostatic	59	 derived	 from	 a	 natural	 pleuromutilin	 that	 binds	 the	 50S	 region	 of	 the	 ribosome	 to	60	 inhibit	 protein	 synthesis	 [22].	 The	 antibiotic	 blocks	 peptide	 bond	 formation	 by	61	 interfering	 with	 substrate	 binding	 [22-25].	 Tiamulin	 treatment	 in	 farms	 generally	62	 results	in	clearance	of	infection	and	associated	symptoms.	However,	reoccurrence	of	the	63	 disease	 can	be	 observed	post	 treatment	 indicating	 incomplete	 clearance	 and	possibly	64	 decreased	 susceptibility	 [26,27]	 in	 response	 to	 treatment.	 The	 reason	 may	 be	 an	65	 inappropriate	 dosing	 as	 there	 is	 currently	 there	 is	 a	 lack	 of	 an	 internationally	66	 recognized	 standardized	 method	 to	 determine	 tiamulin	 minimum	 inhibitory	67	 concentration	 (MIC)	 for	 this	 bacterium,	 which	 has	 impacts	 upon	 selection	 of	 an	68	 appropriate	 treatment	 dose.	 Furthermore,	 recent	 studies	 have	 indicated	 that	69	
Brachyspira	may	 acquire	 resistance	 against	 tiamulin	 and,	 other	 than	 blocking	 protein	70	 synthesis,	nothing	is	yet	known	of	the	metabolic	response	of	B.	pilosicoli	to	tiamulin.	We	71	 argue	 that	 evaluating	 this	 using	 a	 metabonomics	 approach	 would	 allow	 a	 better	72	
understanding	 of	 the	 bacterial	 response	 to	 tiamulin	 and	 give	 insights	 into	 improving	73	 selection	of	effective	dosing	regimes.		74	 Metabonomics	allows	non-targeted	evaluation	of	the	metabolic	modifications	occurring	75	 in	 a	biological	 system	 in	 response	 to	 a	 stress	 [28],	which	 in	 this	 study	 is	 exposure	 to	76	 tiamulin.	 By	 providing	 a	 general	 overview	 of	 the	 metabolic	 response,	 this	 technique	77	 allows	 the	 generation	 of	 new	 hypotheses	 and	 to	 evaluate	 metabolic	 in	 response	 to	78	 environmental	 stress	 or	 genetic	 modification.	 In	 this	 study,	 we	 used	 an	 NMR-based	79	 metabonomics	approach	coupled	with	multivariate	statistics	to	evaluate	the	metabolic	80	 dose-response	 of	B.	pilosicoli	 to	 tiamulin.	 Bacteria	were	 exposed	 to	 gradual	 antibiotic	81	 doses	 and	 media	 were	 sampled	 over	 120h	 in	 order	 to	 evaluate	 the	 evolution	 of	 its	82	 metabolic	composition	during	growth.	This	allowed	to	snapshot	the	metabolic	response	83	 of	B.	pilosicoli	to	tiamulin.	84	 	85	
2.	Material	and	Methods	86	
2.1.	Bacterial	growth	and	antibiotic	assay	87	
B.	pilosicoli	B2904	isolated	from	chicken	presenting	clinical	signs	of	AIS	in	the	UK	[29]	88	 were	 grown	 from	 frozen	 stock	 on	 agar	 solidified	 BEB	 plate	 for	 four	 days	 under	89	 anaerobic	 conditions	 (94%	 N2	and	 6%	 CO2)	 at	 37°C.	 Colonies	 were	 transferred	 into	90	
Brachyspira	enrichment	broth	media	(BEB	supplemented	with	heart	infusion)	for	three	91	 days	under	similar	conditions.	The	bacterial	concentration	was	then	adjusted	in	BEB	to	92	 1	 x	106	CFU/ml	 and	 transferred	 into	24	well	 plates	 (2	ml	per	well)	 and	 incubated	 as	93	 above	 for	 120h.	 Every	 24	 h	 (with	 a	 first	 time	 point	 at	 0	 h	 growth),	 the	 entire	 well	94	 content	was	taken	and	centrifuged	for	2	min	at	2400	g	to	separate	growth	medium	from	95	 bacteria.	 	 The	 supernatant	 was	 kept	 at	 -	 80°C	 for	 further	 analysis.	 This	 process	 was	96	
repeated	at	each	time	point	in	sextuplet	to	deliver	the	appropriate	power	for	statistical	97	 analysis.	98	 The	same	method	was	used	for	the	tiamulin	assay.	Bacterial	cells	were	grown	as	above	99	 and	 bacterial	 pellets	 were	 resuspended	 in	 BEB	 with	 antibiotic	 at	 six	 concentrations	100	 (0.008,	 0.016,	 0.031,	 0.062,	 0.125	 and	 0.250	 µg/ml	 plus	 control).	 Bacteria	were	 then	101	 inoculated	 into	 24	 well	 plates	 as	 previously	 described	 and	 incubated	 for	 120h.	 For	102	 metabolic	analysis,	each	condition	(tiamulin	concentration)	and	time	point	(every	24	h	103	 for	 120	 h)	 were	 also	 repeated	 in	 sextuplet.	 The	 medium	 was	 not	 changed	 for	 the	104	 duration	of	the	experiment	so	that	antibiotic	exposure	was	continuous.		105	 To	evaluate	the	viability	of	B.	pilosicoli	post-	antibiotic	exposure,	the	above	experiment	106	 was	repeated	in	triplicate.	Following	120	h	incubation,	B.	pilosicoli	was	inoculated	onto	107	 fastidious	anaerobic	blood	agar	and	incubated	at	370C,	anaerobically	for	48	h.	Following	108	 incubation	all	plates	were	visually	inspected	for	bacterial	growth.	109	
B.	 pilosicoli	 growth	 was	 evaluated	 using	 the	 same	 experimental	 design	 as	 the	 one	110	 previously	 described.	 Bacteria	 were	 grown	 in	 a	 96	 well	 plate	 (0.2	 ml	 per	 well)	 and	111	 bacterial	growth	was	evaluated	every	2	h	for	120	h	at	an	absorbance	of	600	nm	using	a	112	 Fluostar	(Info).	Water	was	used	as	blank	and	broth	media	without	bacteria	as	a	negative	113	 control.	Each	condition	(tiamulin	concentration)	was	repeated	in	triplicate	and	results	114	 are	presented	as	an	average	of	the	log	of	the	bacterial	concentration	calculated	from	the	115	 absorbance	 observed	 at	 each	 tiamulin	 concentration	 per	 time	 point	 after	 correction	116	 with	standard	curve.	117	 	118	
2.2.	NMR	spectroscopy	119	 For	NMR	spectroscopy,	0.4	ml	of	media	was	added	to	0.2	ml	of	NMR	phosphate	buffer	120	 (made	in	D2O	containing	10	%	water	and	0.05	%	sodium	3-(tri-methylsilyl)	propionate-121	
2,2,3,3-d4	(TSP)	as	a	1H	NMR	reference)	and	0.5	ml	of	the	solution	was	transferred	into	122	 5	mm	of	outer	diameter	NMR	tubes.	1H-NMR	spectra	were	acquired	on	a	Bruker	Avance	123	 DRX	700	MHz	NMR	Spectrometer	(Bruker	Biopsin,	Rheinstetten,	Germany)	operating	at	124	 700.19	 MHz	 and	 equipped	 with	 a	 cryogenic	 probe	 from	 the	 same	 manufacturer.	 A	125	 standard	 1-dimensional	 (1D)	 pulse	 sequence	 [recycle	 delay	 (RD)-90°-t1-90°-tm-90°-126	 acquire	 free	 induction	 decay	 (FID)]	with	water	 suppression	 applied	 during	 RD	 of	 2	s	127	 and	a	mixing	 time	 (tm)	of	100	ms	and	a	90°	pulse	 set	at	10	μs	was	applied.	For	each	128	 spectrum	 128	 scans	 were	 recorded	 on	 a	 total	 of	 32K	 data	 points.	 A	 broadening	 line	129	 function	 of	 0.3	 Hz	 was	 used	 to	 multiply	 all	 FIDs.	 After	 acquisition,	 all	 spectra	 were	130	 manually	 phased	 and	 baseline	 corrected	 using	 the	 software	 MestReNova®	 (version	131	 2.1.8-11880,	MestreLab,	Spain).	Finally,	spectra	were	calibrated	to	the	chemical	shift	of	132	 TSP	(δ	0.00).	In	order	to	facilitate	metabolite	identification	based	on	literature,	a	series	133	 of	2D	spectra	on	selected	samples	were	acquired	using	correlation	spectroscopy	(COSY)	134	 NMR	spectroscopy.	135	 	136	
3.3.	Statistical	analysis	137	 All	 spectra	 were	 scaled	 on	 unit	 variance	 and	 mean	 centered	 prior	 to	 analysis.	 To	138	 evaluate	metabolic	variation	between	samples,	principal	component	analysis	(PCA)	was	139	 used.	Orthogonal	 projection	 to	 latent	 structure	 discriminant	 analysis	 (O-PLS-DA)	was	140	 also	performed,	where	1H-NMR	spectra	were	used	as	a	matrix	of	independent	variables	141	 (X)	and	time	or	antibiotic	concentration	were	used	as	prediction	vectors	(Y)	to	capture	142	 the	metabolic	variations	 linear	 to	 time	and	antibiotic	concentration.	O-PLS	DA	models	143	 were	 generated	 between	 each	 tiamulin	 concentration	 at	 every	 time	 point	144	 independently.	A	heat	map	was	generated	using	each	of	this	model	strength	in	order	to	145	
visualize	when	tiamulin	impacted	bacterial	metabolism	in	comparison	to	control	and	if	146	 clusters	related	to	dose	could	be	observed.		147	 	148	
3.	Results	149	
3.1.	Modifications	of	B.	pilosicoli	metabolism	during	growth	150	 The	 aim	 of	 this	 study	 was	 to	 characterize	 B.	 pilosicoli	 metabolism	 under	 optimum	151	 growth	conditions.	Figure	1	presents	B.	pilosicoli	growth	and	metabolic	activity	in	broth	152	 media.	PC1,	which	captured	49%	of	the	metabolic	variation,	indicated	that	a	significant	153	 metabolic	 shift	was	 recorded	after	96	h	of	 incubation.	Distinctions	between	0	h,	 24	h	154	 and	 48	 h	 were	 observed	 on	 the	 3rd	 component,	 representing	 only	 9%	 of	 the	 total	155	 variation,	 which	 suggests	 a	modest	 effect	 on	 the	 composition	 of	 the	 culture	medium	156	 over	the	first	48	h.	This	metabolic	trajectory	indicates	that	bacterial	metabolism	might	157	 change	depending	on	the	growth	phase	(Figure	1A	and	B).	Scores	from	the	same	time	158	 point	were	clustered	together	indicating	good	reproducibility	of	the	experiment.	159	 In	 the	antibiotic	 free	culture	medium,	 the	growth	of	B.	pilosicoli	was	associated	with	a	160	 decrease	 in	 glucose	 and	 an	 increase	 in	 amino	 acids	 (phenylalanine,	 alanine,	 tyrosine,	161	 lysine,	 valine	 and	 methionine),	 fermentation	 products	 (lactate,	 acetate,	 butyrate	 and	162	 isovalerate),	as	well	as	other	compounds	involved	in	the	regulation	of	cell	osmosis	such	163	 as	myo-inositol	and	trimethylamine	(TMA)	as	observed	in	the	PCA	results	presented	in	164	 Figures	1A	and	C.		165	 Glucose	was	the	only	readily	 identifiable	substrate	 that	showed	a	reduction	over	 time	166	 (Figure	1C).	Decreased	concentration	of	other	substrates	could	not	be	detected	and	it	is	167	 possible	 that	 some	 may	 be	 below	 the	 detection	 limit	 of	 the	 NMR	 instrument.	168	 Nevertheless,	it	is	not	unreasonable	to	assume	that	glucose	was	the	only	carbon	source	169	 used	 for	 bacterial	 anabolism	 and	 growth.	 B.	pilosicoli	 and	 more	 especially	 the	 strain	170	
used	 for	 this	 experiment	 (B2904)	 is	 able	 to	 use	 a	 wide	 range	 of	 carbohydrates	 and	171	 hexoses	as	primary	carbon	sources	[10]	but	it	would	seem	in	this	study	that	glucose	was	172	 used	preferentially.		173	 	174	
3.2.	Tiamulin	impacts	B.	pilosicoli	growth	even	at	very	low	doses	175	 Having	 characterized	 the	 metabolic	 footprint	 of	 B.	 pilosicoli	 when	 grown	 in	 optimal	176	 conditions,	we	then	challenged	it	with	increasing	tiamulin	doses.	Tiamulin	impacted	B.	177	
pilosicoli’s	 growth	 at	 the	 lowest	 concentrations	 tested	 (0.008	 and	 0.016	 µg/mL)	 as	178	 displayed	 in	 Figure	 2.	 For	 these	 two	 doses,	 the	 bacterial	 count	 observed	 at	 the	179	 stationary	 phase	was	 one	 log	 lower	 than	 for	 the	 control	 demonstrating	 the	 ability	 of	180	 tiamulin	 to	 reduce	 the	 growth	 of	B.	pilosicoli	 at	 low	 concentrations.	 Up	 to	 54	 hours,	181	 growth	 curves	 of	 the	 two	 lowest	 concentrations	 (0.008	 and	 0.016	 µg/mL)	 were	182	 identical	to	the	control	(T1	and	T2	on	the	graph)	but	they	stopped	growing	shortly	after	183	 and	 entered	 into	 the	 stationery	 phase.	 No	 bacterial	 growth	 was	 detected	 for	 higher	184	 tiamulin	concentrations	 (over	0.032	µg/mL)	confirming	 its	efficiency	 to	stop	bacterial	185	 proliferation.	Interestingly,	no	gradual	tiamulin	dose	response	of	bacterial	growth	was	186	 observed.	 Indeed,	growth	rates	were	similar	 for	 the	two	 lowest	concentrations	(0.008	187	 and	 0.016	 µg/mL)	 while	 higher	 doses	 induced	 a	 complete	 inhibition	 of	B.	pilosicoli’s	188	 growth.		189	 	190	
3.3.	Metabolic	response	of	B.	pilosicoli	to	tiamulin	191	 A	 clear	 metabolic	 response	 of	 B.	 pilosicoli	 to	 tiamulin	 could	 be	 observed	 when	 the	192	 antibiotic	 dose	 exceeded	 to	 0.032	 µg/mL.	 At	 lower	 doses	 (0.008	 and	 0.016	 µg/mL),	193	 although	 B.	 pilosicoli	 growth	 was	 decreased	 by	 1	 log	 (Figure	 2)	 compared	 with	194	
untreated	 control,	 the	 metabolic	 trajectories	 remained	 unaffected	 (Figure	 3A,	195	 Supplemental	Fig.1	and	2).		196	 When	 bacteria	 were	 exposed	 to	 0.032	 µg/mL	 of	 tiamulin	 (Supplemental	 Fig.	 3),	 a	197	 disruption	of	the	metabolic	trajectory	was	observed	which	was	due	to	modifications	of	198	 amino	 acid	 concentration.	 A	 noticeable	 increase	 of	 tyrosine,	 methionine,	 valine,	199	 phenylalanine	and	lysine	into	the	medium	from	0	to	96	h	was	observed.	After	that	time,	200	 their	concentration	reduced,	indicating	consumption	of	these	amino	acids	until	the	end	201	 of	 the	experiment.	After	120h	of	growth,	 the	metabolic	composition	of	 the	media	was	202	 comparable	 to	 control,	 indicating	 the	 full	 recovery	 of	 the	 metabolism	 following	203	 antibiotic	exposure.	204	 Higher	doses	of	tiamulin	(0.062	and	0.125	µg/mL)	induced	similar	responses	to	those	205	 observed	 at	 0.032	 µg/mL	 (Figure	 3A	 and	 Supplemental	 Fig.	 4.	 A	 and	 B).	 Amino	 acid	206	 metabolism	was	affected	in	a	greater	extent.	207	 At	 the	maximum	dose	tested	(0.250	µg/mL)	the	metabolic	 trajectory	observed	for	 the	208	 media	was	drastically	modified	in	comparison	to	those	described	previously	(Figure	3	209	 and	Supplemental	Fig.	5).	The	metabolic	trajectory	followed	a	circular	shape	where	the	210	 scores	of	the	samples	collected	after	120h	of	bacterial	growth	were	clustered	with	the	211	 ones	 observed	 at	 T0,	 indicating	 metabolic	 similarities	 with	 the	 baseline	 time-point.	212	 Once	again,	amino	acids	were	released	 into	 the	medium	as	well	as	butyrate	and	myo-213	 inositol.	214	 	215	
3.4.	B.	pilosicoli	survives	post-antibiotic	exposure	216	 To	evaluate	the	surviving	potential	of	B.	pilosicoli	after	tiamulin	exposure,	samples	from	217	 replication	of	the	growth	curve	experiment	were	plated	on	agar	plate	at	the	end	of	the	218	 antibiotic	challenge	(120	h).	For	all	tiamulin	doses	applied	it	was	possible	to	observe	B.	219	
pilosicoli	colony	formation	on	agar	plates	(Supplement	Table	1).	These	results	indicate	220	 that	B.	pilosicoli	 is	able	to	recover	from	tiamulin	exposure	(even	at	the	highest	dose	of	221	 0.250	µg/mL)	once	back	in	optimal	growth	conditions.		222	 	223	
4.	Discussion	224	 The	 results	 obtained	 from	B.	pilosicoli	 growth	 in	 a	 control	 medium	without	 tiamulin	225	 provide	new	insights	about	its	general	metabolism.	The	bacteria	were	able	to	produce	226	 lactate	and	acetate	 from	glucose	 fermentation	without	 secreting	methanol,	 suggesting	227	 the	use	of	the	bifidum	pathway	according	to	the	following	equation:	glucose	à	3	acetate	228	 +	 2	 lactate	 [30].	 However,	 lactate	 was	 generally	 found	 in	 very	 small	 quantity	 in	229	 comparison	to	acetate,	indicating	its	potential	use	in	other	metabolic	reactions.	Bacteria	230	 were	also	able	to	secrete	butyric	acid	but	not	propionic	acid.	Both	of	these	short	chain	231	 fatty	acids	were	found	to	be	potential	carbon	sources	for	B.	pilosicoli	[10].	Bacteria	also	232	 released	 a	 large	number	 of	 amino	 acids	 that	 could	be	 caused	 either	 by	 synthesis	 and	233	 active	 secretion	 of	 these	 amino	 acids,	 or	 more	 likely	 due	 to	 exogenous	 protein	234	 degradation.	This	result	is	in	accordance	with	the	genetic	results	published	by	Mappley	235	 et	 al.	 [10]	 that	 indicated	 a	 strong	 proteolytic	 capacity	 of	 the	 bacterium.	 This	 specific	236	 strain	of	B.	pilosicoli	was	also	shown	to	be	able	 to	use	amino	acids	as	primary	carbon	237	 source	 [10].	However,	 as	 the	 bacterium	 favors	 glucose	 if	 available	 as	 primary	 carbon	238	 source,	 amino	 acids	may	 here	 only	 be	 used	 for	 protein	 synthesis	 and	may	 therefore	239	 become	 in	 excess	 in	 the	 culture	medium	where	 they	 accumulate.	 Finally,	 the	bacteria	240	 secreted	TMA.	Gut	bacteria	generally	produce	TMA	from	dietary	L-carnitine,	betaine	or	241	 choline.	 Yet,	 it	 was	 not	 possible	 to	 detect	 a	 decrease	 in	 concentration	 of	 these	242	 compounds	indicating	that	B.	pilosicoli	might	not	use	these	molecules	as	precursors	or	243	 that	the	technique	used	was	not	sensitive	enough	to	detect	such	variations.	244	
More	 importantly,	 this	work	confirmed	 tiamulin	ability	 to	 significantly	 reduce	at	very	245	 low	 doses	 (0.008	 and	 0.016	 µg/mL)	 and	 inhibit	 at	 higher	 concentrations	B.	pilosicoli	246	 growth.	 Decreased	 growth	 rate	 at	 such	 low	 antibiotic	 doses	 were	 unexpected,	 as	247	 previous	evaluation	of	minimum	inhibitory	concentration	(MIC)	values	for	this	specific	248	 strain	were	of	0.250	µg/mL	[31],	furthermore,	10-15%	of	B.	pilosicoli	isolates	presented	249	 MICs	>	4	µg/mL	[31].	Differences	 in	 the	MIC	values	can	be	explained	by	experimental	250	 conditions.	 Growth	 curves	were	 acquired	when	B.	pilosicoli	was	 grown	 in	 BEB	media	251	 rather	than	on	agar	plates	for	MIC	tests.	The	B.	pilosicoli	strain	B2904	used	in	this	study	252	 is	known	to	have	an	MIC	of	0.250	µg/mL	[31,32]	but	showed	clear	inhibition	of	growth	253	 with	 concentrations	 below	 this	 value.	 Thus,	 our	 findings	 confirm	 the	 previously	254	 reported	 observation	 that	 lower	 tiamulin	 MIC	 values	 are	 generally	 found	 in	 broth	255	 compared	to	agar	for	B.	hyodysenteriae	[33].	256	 Despite	 these	 encouraging	 results	 regarding	 tiamulin	 efficiency	 to	 inhibit	 pathogen	257	 growth,	 the	 evaluation	 of	 B.	 pilosicoli	 metabolic	 viability	 in	 response	 to	 antibiotic	258	 treatment	 revealed	 that	 classic	 MIC	 calculations	 might	 not	 be	 sufficient	 to	 assess	259	 antibiotic	 efficiency.	 Indeed,	 B.	 pilosicoli	 metabolic	 rate	 reduction	 did	 not	 mirror	260	 previously	commented	reduced	growth	rate	 in	 response	 to	 tiamulin	 treatment.	At	 the	261	 two	 lowest	 doses	used	 (0.008	 and	0.016	µg/mL),	B.	pilosicoli	 growth	was	 reduced	by	262	 one	log	in	comparison	to	control.	However,	the	metabolic	trajectories	observed	by	the	263	 media	were	 identical.	 Indicating	 that	 tiamulin	was	 able	 to	 impact	 growth	 but	 that	B.	264	
pilosicoli	basic	metabolism	remained	unaffected.	Higher	doses	were	able	to	reduce	but	265	 not	silent	B.	pilosicoli	metabolism	despite	complete	growth	inhibition.	Furthermore,	the	266	 metabolism	of	B.	pilosicoli	appears	 to	slightly	recover	 from	all	 tiamulin	concentrations	267	 except	from	0.250	µg/ml	after	120	h	of	growth.	This	might	be	due	to	the	apparition	of	268	 resistance,	which	is	known	as	being	a	slow	bacterial	development	process	[34,35].		269	
In	 addition,	 it	 was	 demonstrated	 that	 B.	 pilosicoli	 was	 able	 to	 survive	 post-tiamulin	270	 exposure	 even	 at	 the	 highest	 antibiotic	 dose	when	 plated	 on	 agar	 (after	 120	 	 h	 drug	271	 exposure).	 Indeed	 B.	 pilosicoli	 colonies	 were	 identified	 48h	 after	 the	 end	 of	 the	272	 antibiotic	 treatment	 for	 all	 doses	 tested	 (0.008-0.250	µg/mL).	These	 results	 illustrate	273	 the	potential	of	B.	pilosicoli	to	enter	a	dormancy	state	when	exposed	to	tiamulin	that	is	274	 reversible	once	the	treatment	period	is	over.	275	 Besides,	results	demonstrated	a	slow	response	of	the	bacteria	to	antibiotic	treatment	as	276	 modification	 of	 the	 metabolic	 footprint	 was	 only	 observed	 after	 more	 than	 48	 h	 of	277	 growth	 in	 presence	 of	 tiamulin.	 From	 these	 results,	 it	 seems	 that	 metabolism	 was	278	 stressed	 during	 the	 exponential	 phase,	 when	 bacterial	 division	 is	 compromised.	279	 Metabolism	 modification	 was	 mainly	 associated	 with	 increased	 amino	 acid	280	 consumption	(that	were	produced	in	the	control).	However,	as	the	provenance	of	these	281	 amino	acids	remains	unclear,	two	hypotheses	can	be	formulated.	Firstly,	in	response	to	282	 antibiotic	 stress	 bacteria	 could	 use	 amino	 acids	 as	 alternative	 energy	 substrates.	283	 Secondly,	 B.	 pilosicoli	 might	 not	 be	 able	 to	 hydrolyse	 proteins	 present	 in	 the	 media	284	 because	new	protein	synthesis,	such	as	secreted	proteases,	is	blocked	at	the	ribosome.	285	 The	specificity	of	 the	amino	acids	used	 indicates	 the	 first	option	 is	 the	most	probable	286	 and	 that	 catabolism	 repression	 could	 be	 overridden	 to	 secure	 energy	 from	 multiple	287	 sources.	 This	 is	 an	 interesting	 hypothesis	 that	 needs	 confirmation	 by	 alternative	288	 techniques	such	as	transcriptomics.	289	 The	fact	that	B.	pilosicoli	remain	viable	and	metabolically	active	without	dividing	despite	290	 the	 antibiotic	 treatment	 and	 is	 able	 to	 recover	 after	 antibiotic	 exposure	 could	 partly	291	 explain	the	IS	relapse	observed	in	farms	after	tiamulin	intervention.	Indeed,	it	seems	to	292	 arise	from	these	results	that	bacteria	remain	viable	but	are	not	able	to	divide	entering	293	 therefore	a	dormancy	stage.	 It	 is	highly	possible	 that	 such	phenomenon	occurs	 in	 the	294	
intestinal	 lumen,	 where	 bacteria	 could	 suffer	 from	 inactivation	 of	 cell	 division	 but	295	 remain	 viable.	 This	 bacterial	 state	 might	 be	 associated	 with	 a	 decrease	 in	 their	296	 pathogenicity	 explaining	 the	 disappearance	 of	 associated	 symptoms.	 Nevertheless,	297	 bacteria	might	remain	viable	but	at	a	“dormancy”	state	in	the	intestinal	lumen	or	animal	298	 faeces	until	 the	 environment	becomes	 less	hostile	 (end	of	 antibiotic	 treatment)	when	299	 they	 can	 recover	 their	pathogenic	property.	However,	 it	 is	 impotent	 to	point	 out	 that	300	 here	 B.	 pilosicoli	 was	 recovered	 on	 agar	 plates	 that	 represent	 optimal	 growth	301	 conditions.	 This	might	 not	 be	 the	 case	 in	 the	 intestinal	 lumen	 that	 is	 a	more	 hostile	302	 environment	when	the	bacterium	also	needs	to	compete	with	other	commensal	bacteria	303	 and	is	confronted	to	the	host’s	immune	system.		304	 As	 increasing	 antibiotic	 resistance	mechanisms	 developed	 by	 pathogenic	 bacteria	 are	305	 arising,	many	studies	and	reviews	have	stressed	 the	concerns	 linked	 to	 inappropriate	306	 antibiotic	usage.	Indeed,	this	is	strongly	linked	to	development	of	antibiotic	resistance,	a	307	 burden	 for	health	 and	 industry.	 There	 is	 therefore	 a	 surge	 for	 redefining	 appropriate	308	 antibiotic	 use	 that	 would	 help	 minimizing	 the	 current	 concern	 linked	 to	 decreased	309	 antibiotic	 efficiency.	 Thus,	 importance	 should	 be	 given	 to	 new	methods	 development	310	 aiming	 at	 better	 assessing	 antibiotic	 efficiency	 and	 to	 detect	 potential	 antibiotic	311	 resistance	 factor	 development.	 This	 study	 indicates	 that	metabonomics	 could	 be	 and	312	 easy	 and	 practical	 way	 to	 evaluate	 bacterial	 metabolic	 activity	 and	 therefore	 assess	313	 antibiotic	 efficiency	 to	 totally	 inactivate	 pathogens	 and	 therefore	 avoid	 infection	314	 relapse.	315	 	316	
5.	Conclusion	317	 This	work	gave	a	clearer	understanding	of	B.	pilosicoli	metabolism	in	optimum	growth	318	 conditions,	 including	 indication	 regarding	 favored	 fermentation	 pathways	 and	 amino	319	
acids	 metabolism.	 It	 supports	 the	 fact	 that	 tiamulin	 can	 inhibit	 efficiently	 bacterial	320	 growth	at	low	concentrations.	However,	it	was	surprising	to	observe	that	tiamulin	could	321	 impact	B.	pilosicoli	growth	without	influencing	its	basic	metabolism.	It	also	reveals	that	322	 the	bacterium	try	to	maintain	metabolic	homeostasis	despite	an	obvious	stress	visible	323	 on	 the	 growth	 curve,	 demonstrating	 that	 in	 response	 to	 xenobiotic	 stress,	 bacterial	324	 division	 is	 the	 first	 mechanism	 to	 be	 suspended.	 This	 indicates	 that	 tiamulin	 might	325	 present	a	good	solution	against	AIS	outbreaks,	as	it	is	able	to	significantly	reduce	or	stop	326	 bacterial	 growth,	 provided	 that	 the	 efficient	 dose	 is	 achieved	 in	 the	 gut	 of	 every	327	 individual.	Even	so,	the	treatment	may	not	be	sufficient	to	avoid	relapse	of	the	disease.	328	 Such	findings	suggest	that	measurement	of	bacterial	activity	might	be	needed	in	order	329	 to	 assess	 antibiotic	 efficiency	 against	 potential	 reoccurrence	 of	 the	 disease.	 In	 that	330	 prospect,	 metabonomics	 appeared	 as	 a	 potential	 solution	 to	 evaluate	 if	 antibiotic	331	 treatment	can	inactivate	microbial	metabolic	activity.	332	 	333	
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Figures	and	tables	445	 	446	 Figure	 1:	 B.	 pilosicoli	 consumed	 glucose	 and	 released	 amino	 acids	 and	 fermentation	447	 products	 in	 its	 environment.	 (A)	 PCA	 scores	 plot.	 (B)	 B.	 pilosicoli	 growth	 curve	 in	448	
Brachyspira	enrichment	broth	media	under	anaerobic	conditions	made	in	triplicate.	(C)	449	 Associated	loadings	of	the	first	component.	The	metabolic	trajectories	described	by	the	450	 arrows	were	determined	by	the	position	of	the	centroids	calculated	at	each	time	point	451	 using	the	coordinate	of	the	associated	scores	on	the	principal	components.	452	
	453	 Figure	 2:	 Impact	 of	 tiamulin	 on	B.	pilosicoli	 growth	 in	Brachyspira	 enrichment	 broth	454	 media	under	anaerobic	conditions.	Growth	was	measured	in	triplicate	every	2	h	for	120	455	 h.	456	 	457	 Figure	3:	(A)	Metabolic	trajectories	derived	from	the	PCA	analysis	performed	using	all	458	 the	sample	population	(N=252)	of	the	study	(i.e.	control	plus	6	tiamulin	dilution)	on	PC1	459	 and	 PC3	 displaying	 the	 centroids	 for	 each	 time	 points	 of	 the	 control	 and	 three	460	 concentrations	 of	 tiamulin.	 (B)	 Heat	map	 representing	 the	 O-PLS	 DA	model	 strength	461	 existing	 between	 each	 tiamulin	 concentration	 at	 each	 time	 point,	 based	 on	 R2Y	462	 (goodness	 of	 fit	 of	 the	model)	 and	 Q2Y	 (goodness	 of	 prediction	 of	 the	model)	 values	463	 using	the	following	formula:	𝑀𝑜𝑑𝑒𝑙	𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ = 	 ./0	×	2/0./03	2/0 .	464	 	465	
Supplemental	material	466	 	467	 Supplement	 Fig.	 1:	Metabolic	 trajectories	 of	B.	pilosicoli	 footprints	 in	 broth	media	 for	468	 120	h	at	a	tiamulin	concentration	of:	0.008	μg/mL	(A)	and	0.016	μg/mL	(B).	The	arrows	469	 indicate	 the	metabolic	 trajectory.	 The	metabolic	 trajectories	 described	 by	 the	 arrows	470	 were	determined	by	the	position	of	the	centroids	calculated	at	each	time	point	using	the	471	 coordinate	of	the	associated	scores	on	the	PCs.	472	 	473	 Supplement	 Fig.	 2:	 Metabolic	 variation	 related	 to	 PCA	 scores	 plots	 presented	 in	474	 Supplement	Fig.	1.	(A)	loadings	of	the	principal	component	1	of	the	model	presented	in	475	 Fig	 A.1.A.	 (B)	 loadings	 of	 the	 principal	 component	 3	 of	 the	 model	 presented	 in	476	
Supplement	Fig.	1.A.	(C)	loadings	of	the	principal	component	1	of	the	model	presented	477	 in	 Supplement	 Fig.	 1.B.	 (D)	 loadings	 of	 the	 principal	 component	 4	 of	 the	 model	478	 presented	in	Supplement	Fig.	1.B.	479	 	480	 Supplement	Fig.	3:	Metabolic	trajectories	of	B.	pilosicoli	footprint	in	broth	media	for	120	481	 h	at	a	tiamulin	concentration	of	0.032	μg.ml	on	principal	component	1	and	3.	(A)	PCA	482	 score	plot.	(B)	Associated	loading	plot	for	PC1.	The	metabolic	trajectories	described	by	483	 the	 arrows	were	 determined	 by	 the	 position	 of	 the	 centroids	 calculated	 at	 each	 time	484	 point	using	the	coordinate	of	the	associated	scores	on	the	PCs.	485	 	486	 Supplement	Fig.	4:	Metabolic	trajectories	of	B.	pilosicoli	footprint	in	broth	media	for	120	487	 h	 at	 a	 tiamulin	 concentration	 of:	 0.062	 μg/ml	 (A)	 and	 0.125	 μg/ml	 (B).	 The	 arrows	488	 indicate	 the	metabolic	 trajectory.	 The	metabolic	 trajectories	 described	 by	 the	 arrows	489	 were	determined	by	the	position	of	the	centroids	calculated	at	each	time	point	using	the	490	 coordinate	of	the	associated	scores	on	the	PCs.	491	 	492	 Supplement	Fig.	5:	Metabolic	trajectories	of	B.	pilosicoli	footprint	in	broth	media	for	120	493	 h	at	a	tiamulin	concentration	of	0.250	μg/ml.	(A)	PCA	score	plot.	(B)	Associated	loading	494	 plot	 of	 PC1.	 The	 arrows	 indicate	 the	metabolic	 trajectory.	 The	metabolic	 trajectories	495	 described	by	the	arrows	were	determined	by	the	position	of	the	centroids	calculated	at	496	 each	time	point	using	the	coordinate	on	the	associated	scores	on	the	PCs.	497	 	498	 Supplement	Tab.	1:	Growth	scores	of	B.	pilosicoli	on	agar	plate	post-antibiotic	exposure.	499	 Detection	of	B.	pilosicoli’s	growth	48h	after	plating	are	indicated	by	a	sign	‘+’	and	by	‘-‘	if	500	 no	growth	was	observed.	501	
